Jane Lowe Meisel

Dr. Jane Lowe Meisel is a prominent oncologist and co-director of breast medical oncology at the Winship Cancer Institute of Emory University. She is recognized for her expertise in breast cancer treatment and has contributed significantly to clinical research, particularly in targeted therapies for hormone receptor-positive breast cancer. Her insights during the American Society of Clinical Oncology (ASCO) annual meeting highlighted the potential of a new triple therapy that improves survival rates for patients with PIK3CA-mutated breast cancer.